HepaCAM Suppresses Glioblastoma Stem Cell Invasion in the Brain
A. De, J. M. Lattier, J. E. Morales, J. R. Kelly, X. Zheng, Z. Chen, S. Sebastian, J. T. Huse, F. F. Lang, J. H. McCarty
This study shows that hepaCAM suppresses GBM stem cell invasion by balancing ECM adhesion and signaling pathways, suggesting it as a potential therapeutic target.
bioRxiv · Aug 24, 2022 · PreprintCancer Biology